The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
TRANSENTERIX INC COM NEW 89366M201 319 510,142 SH   OTR   0 510,142 0
KALVISTA PHARMACEUTICALS INC COM 483497103 25,679 1,719,576 SH   OTR   0 1,719,576 0
DECIPHERA PHARMACEUTICALS INC COM 24344T101 25,679 449,951 SH   OTR 1,2 0 449,951 0
X4 PHARMACEUTICALS INC COM 98420X103 2,003 311,490 SH   OTR 1,2 0 311,490 0
AVROBIO INC COM 05455M100 16,612 1,191,676 SH   OTR 1,2 0 1,191,676 0
SUTRO BIOPHARMA INC COM 869367102 39,611 1,824,542 SH   OTR   0 1,824,542 0
BICYCLE THERAPEUTICS PLC SPONSORED ADS 088786108 34,379 1,915,274 SH   OTR 1,2 0 1,915,274 0
MISONIX, INC. COM 604871103 21,175 1,694,017 SH   OTR 1,2 0 1,694,017 0
AMERICAN WELL CORP COM NEW 03044L105 42,115 1,662,646 SH   OTR   0 1,662,646 0